Topic
Multipolar World Risks: Geopolitical & Policy Investment Reports
The global landscape is currently defined by a massive, supply-constrained AI buildout, with capital expenditure projected to reach between $990 billion and $1 trillion annually by 2028. This rapid technological expansion is occurring alongside significant geopolitical shifts, including a notable rightward pivot in Colombian politics toward fiscal consolidation and persistent cynicism regarding US-Iran relations that keeps oil prices elevated. In the Middle East, potential de-escalation provides temporary market relief, yet structural risks to energy security via the Strait of Hormuz remain a primary concern for long-term stability. Consequently, institutional research advocates for broadening equity exposure beyond US mega-caps into regions like Japan and China, while diversifying across AI intelligence and application layers to mitigate the risk of incumbent displacement. Furthermore, widespread policy uncertainty is cooling business investment in both Japan and the US factory sector, prompting a tactical shift toward active management and private markets. Ultimately, investors are encouraged to balance enthusiasm for AI beneficiaries with defensive strategies in high-quality government debt and global healthcare to navigate these multifaceted multipolar risks.
6045 reports available
All reports
Page 240 of 252
China AIDC and Power Virtual Corporate Day Takeaways
Goldman Sachs · May 11, 2026
Advanced Products and More Comprehensive Coverage Driving Growth
Goldman Sachs · May 11, 2026
Europe First to Market
J.P. Morgan · May 11, 2026
China AIDC and Power Virtual Corporate Day Takeaways
Goldman Sachs · May 11, 2026
Joby Aviation Flight Demonstrations Underway
Goldman Sachs · May 11, 2026
Leidos Holdings Solid Quarter
Goldman Sachs · May 11, 2026
YOFC New Procurement Tender Released
Goldman Sachs · May 11, 2026
MoonLake Immunotherapeutics 1Q26 Earnings Update
Goldman Sachs · May 11, 2026
The 720: China Internet and Global Market Update
Goldman Sachs · May 11, 2026
The Glory of Low Expectations
The Market Ear · May 11, 2026
Apogee Therapeutics Analysis: Zumilokibart in Atopic Dermatitis
Goldman Sachs · May 11, 2026
House View Daily US
UBS · May 11, 2026
Vontier Corp: Lowering Estimates on Slower Start to the Year
Goldman Sachs · May 11, 2026
Midday Market Intelligence
Goldman Sachs · May 11, 2026
Fluor Corporation 1Q26 Results - Worley Read Through
Goldman Sachs · May 11, 2026
Americas Gaming: Ohio Iowa and Missouri April GGR Update
Goldman Sachs · May 11, 2026
European Retail Virtual Roadshow Key Takeaways
Goldman Sachs · May 11, 2026
Oscar Health 1Q26 Recap Hix Margin Comfort Affirmed Post Oep Growth Burst
Goldman Sachs · May 11, 2026
Urban Company Earnings Review
Goldman Sachs · May 11, 2026
Molina Healthcare Analyst Day Recap
Goldman Sachs · May 11, 2026
Sponsor Activity Barometer
Goldman Sachs · May 11, 2026
Iran War Impact on Chinese Economy and CNY Scenario Analysis
MUFG · May 11, 2026
Saudi Aramco Strong Beat Driven by Both Upstream and Downstream
Goldman Sachs · May 11, 2026
NCR Voyix 1Q26 Takeaways
Goldman Sachs · May 11, 2026